Ablation test results of QIMPN-PCA-DC model. حسب Jun Zhao (59250)

الموضوعات:

IDA flowchart. حسب Jun Zhao (59250)

الموضوعات:

QIMPN framework diagram. حسب Jun Zhao (59250)

الموضوعات:

Multiple indicator test results. حسب Jun Zhao (59250)

الموضوعات:

I/L type node quality entity type. حسب Jun Zhao (59250)

الموضوعات:

Comparison of configuration effects before and after optimizing wall making parameters. حسب Jun Zhao (59250)

الموضوعات:

Test results of inter story displacement angle and shear strength of different models. حسب Jun Zhao (59250)

الموضوعات:

Testing function diagram of QIMPN-PCA-DC. حسب Jun Zhao (59250)

الموضوعات:

Prefabricated shear wall panels and their load-bearing schematic diagram. حسب Jun Zhao (59250)

الموضوعات:

Optimization model for stress parameters of matched shear wall panels. حسب Jun Zhao (59250)

الموضوعات:

PCA-DC cycle improvement process. حسب Jun Zhao (59250)

الموضوعات:

The performance of four algorithms on different datasets. حسب Jun Zhao (59250)

الموضوعات:

Comparison of quality control optimization for anisotropic nodes before and after optimization. حسب Jun Zhao (59250)

الموضوعات:

Node coding process. حسب Jun Zhao (59250)

الموضوعات:

Difference in patients’ outcomes between years 2022 and 2023. حسب Rawan T. Tafish (21736177)

الموضوعات:

Meropenem Consumption Across Quarters of 2022-2023: Defined Daily Dose (Blue Bars) and Antimicrobial Cost per Patient Day (Red Line). حسب Rawan T. Tafish (21736177)

الموضوعات:

Pattern of meropenem prescription expressed as DDD per 1000 across medical specialties: 2022-2023. حسب Rawan T. Tafish (21736177)

الموضوعات:

Quarterly Trends in DDD per 1000 Patient-Days and Statistical Comparisons for 2022–2023. حسب Rawan T. Tafish (21736177)

الموضوعات:

Descriptive Data of Meropenem Compliance Indicators, 2022–2023. حسب Rawan T. Tafish (21736177)

الموضوعات:

Cochran-Armitage Trend test for “Transfer/Discharge” outcome across the quarters of years 2022 and 2023. حسب Rawan T. Tafish (21736177)

الموضوعات: